本文選題：肝癌 + hIL-12��； 參考：《遵義醫(yī)學院》2011年碩士論文

【摘要】：目的：構建真核表達載體pIRES2-EGFP-hIL-12-HSP70,并觀察其轉(zhuǎn)染7402肝癌細胞后的表達情況及對7402肝癌細胞生長的影響,旨在獲得同時具有hIL-12和HSP70活性的雙功能融合蛋白分子。 方法：應用聚合酶鏈反應(PCR)技術,從pBIl21-hIL-12質(zhì)粒中擴增hIL-12基因,從pShuttle-CMV-HSP70質(zhì)粒中擴增HSP70基因,應用基因定向重組技術構建重組真核表達載體pIRES2-EGFP-hIL-12.pIRES2-EGFP-HSP70及pIRES2-EGFP-hIL-12-HSP70,并通過PCR、酶切和DNA測序進行鑒定。用Lipofectamine2000將以上各重組真核表達載體及pIRES2-EGFP(空白對照)質(zhì)粒轉(zhuǎn)染7402肝癌細胞,同時設空細胞組,各組分別命名為7402/hIL-12,7402/HSP70,7402/hIL-12-HSP70,7402/PE,7402/0。通過倒置熒光顯微鏡檢測各組細胞的綠色熒光表達情況；Real-t- ime PCR檢測各重組外源基因在7402肝癌細胞中的表達差異；MTT法檢測細胞生長情況；用AnnexinV-FITC/PI雙染法檢測細胞凋亡率。 結(jié)果：真核表達載體pIRES2-EGFP-hIL-12.pIRES2-EGFP-HSP70及pIRES2-EGFP-hIL-12-HSP70構建成功,通過PCR擴增、酶切及DNA測序證實各插入基因及聯(lián)合基因的大小、位置、方向均正確無誤；各轉(zhuǎn)染組細胞在轉(zhuǎn)染后24h、48h、72h均可在倒置熒光顯微鏡下觀察到綠色熒光；Real-time PCR證明各重組外源基因在已轉(zhuǎn)染重組真核表達載體的7402肝癌細胞中均有表達。MTT法結(jié)果顯示7402/hIL-12-HSP70組細胞的細胞抑制率最高,各處理組細胞48h抑制率明顯高于24h和72h,7402/hIL-12-HSP70組細胞的細胞抑制率與7402/hIL-12組、7402/HSP70組、7402/PE組的差異均有顯著性(P0.05).AnnexinV-FITC/PI雙染法結(jié)果顯示7402/hIL-12-HSP70組細胞較其余各組細胞凋亡數(shù)量增多,7402/hIL-12-HSP70組細胞凋亡數(shù)量與7402/hIL-12組、7402/HSP70組、7402/PE組的差異均有顯著性(P0.05)。 結(jié)論：成功構建了真核表達載體pIRES2-EGFP-hIL-12.pIRES2一EGFP-HSP70及pIRES2-EGFP-hIL-12-HSP70；各重組真核表達載體均能轉(zhuǎn)染進7402肝癌細胞并有效表達；聯(lián)合hIL-12和HSP70基因能明顯地促進7402肝癌細胞凋亡,并具有協(xié)同增強作用。
[Abstract]:Aim: to construct the eukaryotic expression vector pIRES2-EGFP-hIL-12-HSP70 and to observe the expression of pIRES2-EGFP-hIL-12-HSP70 in 7402 hepatoma cells and its effect on the growth of 7402 hepatoma cells. Methods: hIL-12 gene was amplified from pB21-IlhIL-12 plasmid and HSP70 gene was amplified from pShuttle-CMV-HSP70 plasmid by polymerase chain reaction (PCR). Recombinant eukaryotic expression vectors pIRES2-EGFP-hIL-12.pIRES2-EGFP-HSP70 and pIRES2-EGFP-hIL-12-HSP70 were constructed by gene directed recombination technique. The recombinant eukaryotic expression vector and pIRES2-EGFP (blank control) plasmid were transfected into 7402 hepatoma cells with Lipofectamine 2000. The cells were divided into empty cell group and named 7402% hIL-127402% HSP70402% hIL-12-HSP702% PE7402% 0 / 0 respectively. The green fluorescence expression of each group was detected by inverted fluorescence microscope. Real-time ime was used to detect the difference of the expression of the recombinant foreign genes in 7402 hepatoma cells. The growth of the cells was detected by MTT assay. Results: the eukaryotic expression vector pIRES2-EGFP-hIL-12.pIRES2-EGFP-HSP70 and pIRES2-EGFP-hIL-12-HSP70 were successfully constructed. The size, position and direction of each inserted gene and associated gene were correct by PCR amplification, restriction endonuclease digestion and DNA sequencing. In each transfection group, at 24 h after transfection, 48 h and 72 h after transfection, green fluorescent real-time PCR was observed under inverted fluorescence microscope to demonstrate that all recombinant foreign genes were expressed in 7402 hepatoma cells transfected with recombinant eukaryotic expression vector. MTT assay showed that 7402% hIL-12-HSP70 was detected by MTT assay. The cell inhibition rate of the group was the highest. The cell inhibition rate in each treatment group was significantly higher than that in 24 h and 72 h / 7402% hIL-12-HSP70 group and 7402% hIL-12 / HSP70 group respectively. There were significant differences in cell apoptosis between 7402% hIL-12 / HSP70 group and 7402% HSP12 / HSP70 group. The results of Annexin V-FITCPI double staining showed that 7402 hIL-12-HSP70 cells increased the number of apoptosis in 7402 hIL-12-HSP70 group compared with the other groups. There was significant difference in apoptosis between 7402% HSP70 group and 7402% HSP70 group. Conclusion: the eukaryotic expression vectors pIRES2-EGFP-hIL-12.pIRES2-EGFP-HSP70 and pIRES2-EGFP-hIL-12-HSP70 were successfully constructed and each recombinant eukaryotic expression vector could be transfected into 7402 hepatoma cells and expressed effectively. The combination of hIL-12 and HSP70 gene can obviously promote apoptosis of 7402 hepatoma cells and has synergistic effect.
【學位授予單位】：遵義醫(yī)學院
【學位級別】：碩士
【學位授予年份】：2011
【分類號】：R346

【參考文獻】

相關期刊論文 前8條

1 鄧小玲,陳瑋,蔡美英,魏大鵬,宋小玉;原發(fā)性肝癌HSP70和MHC Ⅰ類分子的表達[J];臨床肝膽病雜志;2003年01期

2 陳世f^;陳駿;徐衛(wèi)東;尹國文;席瑋;;動脈灌注p53基因治療晚期肝癌的初步臨床應用[J];介入放射學雜志;2007年02期

3 胡沛臻,楊守京,馬福成,劉彥仿;人原發(fā)性肝細胞癌中熱休克蛋白70mRNA的表達[J];診斷病理學雜志;2001年04期

4 王季X,喬世峰;反義IGF-Ⅰ寡核苷酸轉(zhuǎn)染抑制人肝癌細胞生長的實驗觀察[J];中國腫瘤臨床;2005年02期

5 傅慶國,孟凡東,沈曉東,郭仁宣;腫瘤熱休克蛋白70聯(lián)合IL-2對荷瘤小鼠的治療作用[J];細胞與分子免疫學雜志;2003年01期

6 穆紅;王玉亮;劉蓉;;野生型p53基因在人肝癌細胞的表達及誘導其凋亡[J];細胞與分子免疫學雜志;2006年06期

7 馬毅;陳祖兵;華峗鵬;;腺病毒介導雙自殺基因CD／TK對人肝癌細胞株Bel7402的抑制作用[J];中華實驗外科雜志;2006年05期

8 尹燕明,秦慶亮,張偉,趙晶,張長麗,于建國;肝細胞癌熱休克蛋白70過表達與自發(fā)性癌細胞凋亡[J];中華肝臟病雜志;2001年02期

，

本文編號：2001809